002950.SZ SHZ
Allmed Medical Products Co.,Ltd
1W: -1.0%
1M: -7.1%
3M: -8.3%
YTD: -22.9%
1Y: -12.0%
3Y: -16.8%
5Y: -45.3%
¥8.54 ($1.28)
+0.12 (+1.43%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$3.3B
+20.7% ▲
5Y CAGR: +7.2%
Gross Profit
$957M
+45.5% ▲
5Y CAGR: +3.7%
Operating Income
$458M
+171.2% ▲
5Y CAGR: +3.3%
Net Income
$369M
+233.9% ▲
5Y CAGR: +2.5%
EPS (Diluted)
$0.59
+247.1% ▲
5Y CAGR: +3.0%
EBITDA
$709M
+65.5% ▲
5Y CAGR: +4.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $3.8B | $2.9B | $4.2B | $2.8B | $3.3B |
| YoY Growth | +63.0% | -23.7% | +43.9% | -34.5% | +20.7% |
| Cost of Revenue | $2.2B | $2.0B | $2.8B | $2.1B | $2.4B |
| Gross Profit | $1.6B | $882M | $1.4B | $658M | $957M |
| Gross Margin | 41.7% | 30.1% | 33.6% | 23.9% | 28.8% |
| R&D Expenses | $118M | $95M | $108M | $77M | $106M |
| SG&A Expenses | $90M | $141M | $182M | $93M | $5M |
| Operating Expenses | $354M | $423M | $539M | $489M | $499M |
| Operating Income | $1.3B | $506M | $525M | $169M | $458M |
| Operating Margin | 35.0% | 17.3% | 12.5% | 6.1% | 13.8% |
| Interest Expense | $18M | $23M | $42M | $33M | $27M |
| Income Before Tax | $1.3B | $505M | $485M | $169M | $454M |
| Tax Expense | $178M | $74M | $80M | $65M | $86M |
| Net Income | $1.2B | $431M | $407M | $110M | $369M |
| Net Margin | 30.2% | 14.7% | 9.7% | 4.0% | 11.1% |
| EPS (Diluted) | $1.83 | $0.68 | $0.64 | $0.17 | $0.59 |
| EBITDA | $1.5B | $673M | $715M | $428M | $709M |
| Shares Outstanding | 633M | 633M | 633M | 649M | 625M |